Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-04

Clinical Trial Update: Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing quetiapine fumarate (SEROQUEL) to placebo in adolescents with schizophrenia has completed, per the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED